Drug Shortage Report for RATIO-IPRA SAL UDV

Last updated on 2017-07-28 History
Report ID 3137
Drug Identification Number 02243789
Brand name RATIO-IPRA SAL UDV
Common or Proper name IPRATROPIUM/SALBUTAMOL
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) IPRATROPIUM BROMIDE SALBUTAMOL
Strength(s) 0.5MG 2.5MG
Dosage form(s) SOLUTION
Route of administration INHALATION
Packaging size 20X2.5ML
ATC code R03AL
ATC description ADRENERGICS, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-17
Estimated end date 2017-06-28
Actual end date 2017-07-27
Shortage status Resolved
Updated date 2017-07-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2017-07-28 English Compare
v11 2017-07-27 French Compare
v10 2017-07-27 English Compare
v9 2017-05-08 French Compare
v8 2017-05-08 English Compare
v7 2017-04-25 French Compare
v6 2017-04-25 English Compare
v5 2017-04-03 French Compare
v4 2017-04-03 English Compare
v3 2017-03-18 English Compare
v2 2017-03-17 French Compare
v1 2017-03-17 English Compare

Showing 1 to 12 of 12